business2 min read2h ago
UniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agency
CNBCNewswireWednesday, June 17, 2026
Desk Brief
The announcement comes months after UniQure became embroiled in a public debate with FDA leaders over the clinical trial data supporting its application.
The announcement comes months after UniQure became embroiled in a public debate with FDA leaders over the clinical trial data supporting its application.
The announcement comes months after UniQure became embroiled in a public debate with FDA leaders over the clinical trial data supporting its application.
This article is sourced from CNBC. For the complete story, analysis, and additional context, read the full article.